Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

5AM Ventures Assists in Launching New Term Sheet Template for Early-Stage Life Science Startups Emerging from Academic Research Labs
Read Me

Arvinas Announces ARV-471 Achieves a Clinical Benefit Rate of 38% in Evaluable Patients and Continues to Show a Favorable Tolerability Profile in its Phase 2 Expansion Trial (VERITAC)
Read Me

scPharmaceuticals Announces Pricing of $50 Million Public Offering
Read Me

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock
Read Me

Escient Pharmaceuticals Initiates Phase 2 PACIFIC Study Evaluating EP547, An Oral MRGPRX4 Antagonist, in Subjects with Cholestatic Pruritus

Pushing the healthcare industry forward

$ 0 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $450M from 5AM Ventures VII and $300M from 5AM Opportunities II.
0

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
0

ONGOING CLINICAL TRIALS

Historically our portfolio companies have had over 80,000 patients enrolled across 8,000 test sites in clinical trials.

San Francisco, CA

Boston, MA

© 2022 5AM Venture Management LLC